Pharmaceuticals

In the last 24 hours

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis Pharmacy Times14:44 16-Jun-25

Belgian pharma company to invest $5bn on US factory Global Construction Review09:36 16-Jun-25

Spotlight On: Lantus® / Lantus® SoloSTAR® (insulin glargine recombinant) / Basaglar® (insulin glargine) / Semglee®… JD Supra12:58 16-Jun-25

FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA Pharmacy Times12:02 16-Jun-25

Shilpa Medicare and Orion partner, expanding into European market Pharmafile09:42 16-Jun-25

Aquestive Therapeutics's NDA For Anaphylm Receives FDA Acceptance, Stock Up In Pre-Market RTT News08:19 16-Jun-25

After rebuffing Biogen, Sage pairs off with Supernus pharmaphorum09:57 16-Jun-25

view more headlines

In the last 4 days

Bristol Myers Squibb reports positive results for psoriatic arthritis treatment Pharmafile07:37 13-Jun-25

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial… The Times of India08:35 14-Jun-25

Sun Pharma's Halol plant gets 8 USFDA observations post inspection The Business Standard06:26 14-Jun-25

Sun Pharma gets eight observations from USFDA for Halol plant The Times of India06:21 14-Jun-25

Sun Pharma updates on US FDA inspection The Business Standard03:15 14-Jun-25

Once-a-week pill may treat schizophrenia effectively Knowridge Science Report22:38 13-Jun-25

Pharma department refuses to name 30 doctors in bribery tangle The Times of India21:26 13-Jun-25

STAT Plus: Anne Wojcicki wins back 23andMe, this time as a nonprofit STAT18:20 13-Jun-25

SII, DNDi partner for expanding human trials for dengue treatment The Hindu15:55 13-Jun-25

Pfizer’s $6.15B 3Sbio deal tops May’s biopharma activity BioWorld15:42 13-Jun-25

STAT Plus: RFK Jr.’s new vaccine panel raises questions of how Kennedy defines conflicts of… STAT15:36 13-Jun-25

Quietly Beating Cancer? Lost in Prior Authorization; FDA Generic Drug Office Lives Medpage Today15:28 13-Jun-25

Texas governor signs bill allocating up to $100 million in funding for psychedelics research San Antonio Current14:29 13-Jun-25

Competing with the dragon The Financial Express14:16 13-Jun-25

EVERSANA expands commercialisation portfolio with OS Therapi... pharmaphorum11:18 13-Jun-25

Sanders, King introduce bill banning prescription drug ads Just The News09:23 13-Jun-25

A new era in migraine treatment: Innovative drugs redefining the field Labiotech09:10 13-Jun-25

Novo Nordisk regains crown as Europe's most valuable firm RTE07:40 13-Jun-25

EpiEndo publishes new data supporting glasmacinal’s potential in COPD Pharmafile07:37 13-Jun-25

Moderna's RSV shot gets US nod for use in younger adults pharmaphorum07:34 13-Jun-25

GSK’s Blenrep combination recommended by NICE to treat multiple myeloma PMLiVE07:24 13-Jun-25

Pushback rises against RFK Jr's new ACIP membership pharmaphorum06:33 13-Jun-25

Orion chooses Shilpa Biocare to supply recombinant human albumin protein Manufacturing Chemist05:27 13-Jun-25

AstraZeneca boosts China ties with up to USD5.3 billion partnership London South East05:22 13-Jun-25

GSK seeks broader European approval for RSV vaccine Proactive Investors (UK)05:07 13-Jun-25

view more headlines

In the last 7 days

Bulgaria backs pharma package in principle, wants reimbursement backstop in trilogue EurActiv.com08:41 10-Jun-25

First-in-Class Lupus Drug Aces Phase III Test Medpage Today12:20 12-Jun-25

Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results Benzinga11:59 12-Jun-25

FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection Benzinga13:57 11-Jun-25

Maker of Sexual Desire Drug Addyi Gets FDA Warning Letter Medpage Today12:14 11-Jun-25

3 Penny Stocks Wall Street Sees With 243% Upside 24/7 Wall St.09:35 11-Jun-25

Marvel's latest superhero aims to smash diabetes stigma pharmaphorum09:29 11-Jun-25

Teva’s Orange Book Defeat Sparks Pharma-Patent Strategy Overhaul Bloomberg Law05:12 11-Jun-25

Chinese Firm Halts Production of Controversial Alzheimer’s Drug Mint05:09 10-Jun-25

CureVac to Be Acquired by BioNTech in $1.25B Deal to Advance mRNA Cancer Therapies PharmTech.com16:12 12-Jun-25

Chancery Tags AstraZeneca Unit For $180M 'Expectation' Loss Law36013:56 12-Jun-25

Mitomycin Intravesical Solution Received FDA Approval for Non-Muscle Invasive Bladder Cancer Pharmacy Times13:39 12-Jun-25

Do We Really Pay More for Prescription Drugs in the United States? Pharmacy Times10:04 12-Jun-25

Colorectal cancer red flags often mistaken for medication side effects Hospital Pharmacy Europe07:38 12-Jun-25

Novo Nordisk teams up with NVIDIA on AI models pharmaphorum06:39 12-Jun-25

Concerns rise over ACIP's new membership pharmaphorum05:38 12-Jun-25

Bharat Biotech, GSK team up to develop Shigella vaccine for global health The Hindu Business Line04:01 12-Jun-25

FDA Approves Tablet Formulation of Zanubrutinib for All Indications Pharmacy Times17:29 11-Jun-25

RFK Jr. names new members of CDC’s vaccine advisory panel STAT17:03 11-Jun-25

Teva’s Next-Gen Trail Running Sandal Is Not Only Lighter — It’s Cheaper Too Gear Patrol12:08 11-Jun-25

Czech innovative drug makers welcome Council pharma deal ahead of trilogue EurActiv.com11:17 11-Jun-25

European Commission approves treatment for Duchenne muscular dystrophy European Pharmaceutical Manufacturer11:13 11-Jun-25

Scorpion, fresh off Lilly deal, spins out startup Antares BioPharma Dive10:18 11-Jun-25

Radiopharm Gets FDA Fast Track Designation For RAD101, To Advance Phase 2 Clinical Trial; Stock Up RTT News09:33 11-Jun-25

STAT Plus: Pharmalittle: We’re reading about Trump and drug prices, Gilead trial delays, and… STAT09:20 11-Jun-25

view more headlines

In the last 14 days

Kymera STAT6 Data Set The Bar For ‘Dupixent-In-A-Pill’ Race Scrip Pharma Intelligence16:51 3-Jun-25

Merck's cholesterol drug meets main goal in two studies Reuters07:30 9-Jun-25

AstraZeneca CEO suggests cause behind high drug prices Fox News16:21 4-Jun-25

Wockhardt eyes USD 7 billion market opportunity for antibiotic Zaynich in US, Europe The Times of India08:11 5-Jun-25

MHRA advises contraception for women taking 'skinny jabs' pharmaphorum06:32 5-Jun-25

STAT Plus: MoonLake Immunotherapeutics is for sale? This sounds like a cry for help STAT06:32 5-Jun-25

BMS wins Korean nod for Augtyro, joining Roche and Bayer in tumor-agnostic cancer race Korea Biomedical Review05:00 5-Jun-25

FDA to Meet Drug Approval Goals Despite Cuts, Commissioner Says Bloomberg Law17:07 4-Jun-25

Camurus, Lilly Sign Up tp $870m Deal for Incretin Therapies Bloomberg Law14:01 3-Jun-25

Activist hedge fund builds stake in Ozempic-maker Novo Nordisk The Irish Times13:39 9-Jun-25

George gets FDA nod for first blood pressure triple therapy pharmaphorum09:10 9-Jun-25

STAT Plus: Merck gets lift from U.S. patent office in battle over injectable form of Keytruda STAT13:27 4-Jun-25

Ed Silverman STAT08:52 4-Jun-25

FDA approves YolTech’s YOLT-101 for familial hypercholesterolemia Pharmaceutical Technology11:54 9-Jun-25

Exclusive: Pangea Data, AstraZeneca's Alexion partner to spot rare disease with EHRs MobiHealthNews08:08 9-Jun-25

The dapagliflozin case: guidance on generic launches Mishcon de Reya (Press Release)07:45 6-Jun-25

Mhra issues first UK guidance on phage therapies European Pharmaceutical Review07:44 5-Jun-25

Insilico’s IPF drug demonstrated ‘clinically meaningful’ benefits in trial Longevity Technology13:09 4-Jun-25

Biotech funding plummets as Trump policies unnerve investors: Jefferies BioPharma Dive12:38 4-Jun-25

Regeneron boosts obesity pipeline with Hansoh’s GLP-1/Gip for $2B BioWorld14:52 3-Jun-25

The Future Of Drug Trials Might Be Virtual AI Patients Forbes08:07 3-Jun-25

AI Meets IPF: Taking an AI-Designed Drug from Target Discovery to Phase IIa Behavioural and Social Sciences at Nature Research05:14 3-Jun-25

AstraZeneca Pharma slides as MD Sanjeev Panchal steps down; Praveen Rao Akkinepally to take charge The Business Standard00:49 10-Jun-25

Pharma opportunity The Hindu Business Line21:01 9-Jun-25

Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's… FiercePharma16:43 9-Jun-25

view more headlines

About our Pharmaceuticals news

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.